Thyrocare Technologies (NSE:THYROCARE) Marketable Securities : ₹1,753 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Thyrocare Technologies's Marketable Securities for the quarter that ended in Mar. 2025 was ₹1,753 Mil.

Thyrocare Technologies's annual Marketable Securities increased from Mar. 2023 (₹1,223 Mil) to Mar. 2024 (₹1,368 Mil) and increased from Mar. 2024 (₹1,368 Mil) to Mar. 2025 (₹1,753 Mil).

Thyrocare Technologies Marketable Securities Historical Data

The historical data trend for Thyrocare Technologies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Marketable Securities Chart

Thyrocare Technologies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Marketable Securities

Get a 7-Day Free Trial

1,044.90

1,252.10

1,223.00

1,368.10

1,753.10

Thyrocare Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															1,368.10	-	943.30	-	1,753.10

Thyrocare Technologies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Thyrocare Technologies (NSE:THYROCARE) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Thyrocare Technologies Marketable Securities Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Thyrocare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

539871:India

Address

D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703

Website

https://www.thyrocare.com

Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines